Inactive Instrument

News Quest PharmaTech Inc. Other OTC

Equities

QPTFF

CA74836M1068

Summary

Unlock all the news: Be the first to know and act before the market!

Quest PharmaTech Inc. Reports Earnings Results for the First Quarter Ended April 30, 2024	Jun. 28	CI
Quest PharmaTech Announces Filing of 2024 Year End Financial Statements and Restated Fiscal 2023 Financial Statements, and Appointment of New Director	May. 30	AQ
Quest Pharmatech Inc. Announces the Appointment of Bradley J. Glass to the Board of Directors	May. 30	CI
Quest PharmaTech Inc. Reports Earnings Results for the Full Year Ended January 31, 2024	May. 29	CI
Quest PharmaTech Brief: Says Quest has a 42.5% ownership interest in OncoQuest; Adds dividend income will be used by Quest for general corporate purposes	Jan. 30	MT
Quest PharmaTech Brief: Received a cash dividend payment from OncoQuest Inc. of approximately C$685,000	Jan. 30	MT
Quest Receives Cash Dividend Payment from OncoQuest	Jan. 30	AQ
Quest PharmaTech Inc. Says Oregovomab Phase III Clinical Study Fails Futility Analysis	Jan. 24	MT
Quest PharmaTech Inc. - Oregovomab Phase III Clinical Study fails futility analysis, Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits	Jan. 24	AQ
Oregovomab Phase III Clinical Study fails futility analysis; Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits	Jan. 23	AQ
Quest PharmaTech Inc. Receives Recommendations from the Data Safety Monitoring Board to Discontinue Oregovomab Phase III Clinical Study	Jan. 23	CI
Quest PharmaTech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	Dec. 13	CI
Quest PharmaTech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	23-09-21	CI
Quest PharmaTech Provides Corporate Update	23-09-13	AQ
Quest PharmaTech Announces Results from AGM	23-07-14	AQ
Quest PharmaTech Provided Product Development Update	23-07-10	MT
Quest PharmaTech Provides Product Development Update	23-07-10	AQ
Quest PharmaTech Inc. Provides Product Development Update	23-07-10	CI
Quest PharmaTech Inc. Reports Earnings Results for the First Quarter Ended April 30, 2023	23-06-29	CI
Quest PharmaTech Provides Corporate Update	23-06-09	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Quest PharmaTech Inc. Other OTC

Equities

QPTFF

CA74836M1068

Summary

Filters